2023 annual financial data
Adial Pharmaceuticals 2023 Operating margin
Adial Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,887,947 USD and net income was -7,001,890 USD.
Operating cash flow was -6,806,809 USD.
Get free Adial Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,887,947 USD
- Net income
- -7,001,890 USD
- Operating cash flow
- -6,806,809 USD